Gadoxetic Acid Uptake Rate as a Measure of Global and Regional Liver Function as Compared With Indocyanine Green Retention, Albumin-Bilirubin Score, and Portal Venous Perfusion
- PMID: 35496263
- PMCID: PMC9048078
- DOI: 10.1016/j.adro.2022.100942
Gadoxetic Acid Uptake Rate as a Measure of Global and Regional Liver Function as Compared With Indocyanine Green Retention, Albumin-Bilirubin Score, and Portal Venous Perfusion
Abstract
Purpose: Global and regional liver function assessments are important for defining the magnitude and spatial distribution of dose to preserve functional liver parenchyma and reduce incidence of hepatotoxicity from radiation therapy for intrahepatic cancer treatment. This individualized liver function-guided radiation therapy strategy is critical for patients with heterogeneous and poor liver function, often observed in cirrhotic patients treated for hepatocellular carcinoma. This study aimed to validate k1 as a measure of global and regional function through comparison with 2 well-regarded global function measures: indocyanine green retention (ICGR) and albumin-bilirubin (ALBI).
Methods and materials: Seventy-nine dynamic gadoxetic acid enhanced magnetic resonance imaging scans were acquired in 40 patients with hepatocellular carcinoma in institutional review board approved prospective protocols. Portal venous perfusion (kpv ) was quantified from gadoxetic acid enhanced magnetic resonance imaging using a dual-input 2-compartment model, and gadoxetic acid uptake rate (k1) was fitted using a linearized single-input 2-compartment model chosen for robust k1 estimation. Four image-derived measures of global liver function were tested: (1) mean k1 multiplied by liver volume (k1VL ) (functional volume), (2) mean k1 multiplied by blood distribution volume (k1Vdis ), (3) mean kpv, and (4) liver volume (VL ). The measure's correlation with corresponding ICGR and ALBI tests was assessed using linear regression. Voxel-wise similarity between k1 and kpv was compared using Spearman ranked correlation.
Results: Significant correlations (P < .05) with ICGR and ALBI were found for k1VL, k1Vdis, and VL (in order of strength), but not for mean pv The mean ranked correlation coefficient between k1 and kpv maps was 0.09. k1 and kpv maps were predominantly mismatched in patients with poor liver function.
Conclusions: The metric combining function and liver volume (k1VL ) was a stronger measure of global liver function compared with perfusion or liver volume alone, especially in patients with poor liver function. Gadoxetic acid uptake rate is promising for both global and regional liver function.
© 2022 The Authors.
Figures




Similar articles
-
Assessing the Relationship Between MR-Based Functional Dose Metrics and Post-Stereotactic Body Radiation Therapy Albumin-Bilirubin Change.Int J Radiat Oncol Biol Phys. 2025 Jul 1;122(3):690-697. doi: 10.1016/j.ijrobp.2025.03.054. Epub 2025 Mar 31. Int J Radiat Oncol Biol Phys. 2025. PMID: 40202481
-
Quantification of liver function by linearization of a two-compartment model of gadoxetic acid uptake using dynamic contrast-enhanced magnetic resonance imaging.NMR Biomed. 2018 Jun;31(6):e3913. doi: 10.1002/nbm.3913. Epub 2018 Apr 19. NMR Biomed. 2018. PMID: 29675932 Free PMC article.
-
The Effect of Stereotactic Body Radiation Therapy for Hepatocellular Cancer on Regional Hepatic Liver Function.Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):794-802. doi: 10.1016/j.ijrobp.2022.09.077. Epub 2022 Sep 28. Int J Radiat Oncol Biol Phys. 2023. PMID: 36181992
-
Diffusion/perfusion MR imaging of the liver: practice, challenges, and future.Magn Reson Med Sci. 2012;11(3):151-61. doi: 10.2463/mrms.11.151. Magn Reson Med Sci. 2012. PMID: 23037559 Review.
-
Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging.Eur Radiol. 2021 Aug;31(8):5615-5628. doi: 10.1007/s00330-020-07637-4. Epub 2021 Feb 1. Eur Radiol. 2021. PMID: 33523304 Free PMC article. Review.
Cited by
-
Role of Functional MRI in Liver SBRT: Current Use and Future Directions.Cancers (Basel). 2022 Nov 28;14(23):5860. doi: 10.3390/cancers14235860. Cancers (Basel). 2022. PMID: 36497342 Free PMC article. Review.
-
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer.Cancer J. 2023 Sep-Oct 01;29(5):266-271. doi: 10.1097/PPO.0000000000000679. Cancer J. 2023. PMID: 37796644 Free PMC article. Review.
-
Assessing the Relationship Between MR-Based Functional Dose Metrics and Post-Stereotactic Body Radiation Therapy Albumin-Bilirubin Change.Int J Radiat Oncol Biol Phys. 2025 Jul 1;122(3):690-697. doi: 10.1016/j.ijrobp.2025.03.054. Epub 2025 Mar 31. Int J Radiat Oncol Biol Phys. 2025. PMID: 40202481
-
PET/CT-Based Absorbed Dose Maps in 90Y Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRI.J Nucl Med. 2024 Aug 1;65(8):1224-1230. doi: 10.2967/jnumed.124.267421. J Nucl Med. 2024. PMID: 38960710 Free PMC article.
References
-
- Yoon HI, Koom WS, Lee IJ, et al. The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma. Liver Int. 2012;32:1165–1171. - PubMed
-
- Oellerich M, Burdelski M, Lautz HU, Binder L, Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology. 1991;14:1029–1034. - PubMed
-
- Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53:810–821. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources